Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Innoviva Inc has a consensus price target of $15.17 based on the ratings of 4 analysts. The high is $22.5 issued by EF Hutton on May 10, 2023. The low is $10 issued by Morgan Stanley on March 3, 2023. The 3 most-recent analyst ratings were released by EF Hutton, EF Hutton, and Goldman Sachs on May 10, 2023, April 20, 2023, and March 3, 2023, respectively. With an average price target of $19.33 between EF Hutton, EF Hutton, and Goldman Sachs, there's an implied 1.81% upside for Innoviva Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Innoviva (NASDAQ:INVA) was reported by Cantor Fitzgerald on August 1, 2024. The analyst firm set a price target for $0.00 expecting INVA to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Innoviva (NASDAQ:INVA) was provided by Cantor Fitzgerald, and Innoviva reiterated their overweight rating.
There is no last upgrade for Innoviva
There is no last downgrade for Innoviva.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Innoviva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Innoviva was filed on August 1, 2024 so you should expect the next rating to be made available sometime around August 1, 2025.
While ratings are subjective and will change, the latest Innoviva (INVA) rating was a reiterated with a price target of $0.00 to $0.00. The current price Innoviva (INVA) is trading at is $18.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.